Literature DB >> 21797691

Multifaceted interactions of bacterial toxins with the gastrointestinal mucosa.

M R Popoff1.   

Abstract

The digestive tract is one of the ecosystems that harbors the largest number and greatest variety of bacteria. Among them, certain bacteria have developed various strategies, including the synthesis of virulence factors such as toxins, to interact with the intestinal mucosa, and are responsible for various pathologies. A large variety of bacterial toxins of different sizes, structures and modes of action are able to interact with the gastrointestinal mucosa. Some toxins, termed enterotoxins, directly stimulate fluid secretion in enterocytes or cause their death, whereas other toxins pass through the intestinal barrier and disseminate by the general circulation to remote organs or tissues, where they are active. After recognition of a membrane receptor on target cells, toxins can act at the cell membrane by transducing a signal across the membrane in a hormone-like manner, by pore formation or by damaging membrane compounds. Other toxins can enter the cells and modify an intracellular target leading to a disregulation of certain physiological processes or disorganization of some structural architectures and cell death. Toxins are fascinating molecules, which mimic or interfere with eukaryotic physiological processes. Thereby, they have permitted the identification and characterization of new natural hormones or regulatory pathways. Besides use as protective antigens in vaccines, toxins offer multiple possibilities in pharmacology, such as immune modulation or specific delivery of a protein of interest into target cells.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21797691     DOI: 10.2217/fmb.11.58

Source DB:  PubMed          Journal:  Future Microbiol        ISSN: 1746-0913            Impact factor:   3.165


  8 in total

Review 1.  Animal Enterotoxigenic Escherichia coli.

Authors:  J Daniel Dubreuil; Richard E Isaacson; Dieter M Schifferli
Journal:  EcoSal Plus       Date:  2016-10

2.  Staphylococcus aureus enterotoxins A- and B: binding to the enterocyte brush border and uptake by perturbation of the apical endocytic membrane traffic.

Authors:  E Michael Danielsen; Gert H Hansen; Edda Karlsdóttir
Journal:  Histochem Cell Biol       Date:  2012-11-23       Impact factor: 4.304

Review 3.  Small Intestinal Infections.

Authors:  Khushboo Munot; Donald P Kotler
Journal:  Curr Gastroenterol Rep       Date:  2016-06

4.  Clarification of linaclotide pharmacology presented in a recent clinical study of plecanatide.

Authors:  Robert W Busby; Stephan Ortiz
Journal:  Dig Dis Sci       Date:  2014-03-21       Impact factor: 3.199

Review 5.  Non-Digestible Oligosaccharides and Short Chain Fatty Acids as Therapeutic Targets against Enterotoxin-Producing Bacteria and Their Toxins.

Authors:  Mostafa Asadpoor; Georgia-Nefeli Ithakisiou; Paul A J Henricks; Roland Pieters; Gert Folkerts; Saskia Braber
Journal:  Toxins (Basel)       Date:  2021-02-25       Impact factor: 4.546

6.  Modulating the Global Response Regulator, LuxO of V. cholerae Quorum Sensing System Using a Pyrazine Dicarboxylic Acid Derivative (PDCApy): An Antivirulence Approach.

Authors:  M Hema; Sahana Vasudevan; P Balamurugan; S Adline Princy
Journal:  Front Cell Infect Microbiol       Date:  2017-10-12       Impact factor: 5.293

7.  Effect of Montmorillonite powder on intestinal mucosal barrier in children with abdominal Henoch-Schonlein purpura: A randomized controlled study.

Authors:  Xiaolin Gao; Ruixue Miao; Yuhong Tao; Xiuying Chen; Chaomin Wan; Ruizhen Jia
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.889

Review 8.  Clostridium Bacteria and Autism Spectrum Conditions: A Systematic Review and Hypothetical Contribution of Environmental Glyphosate Levels.

Authors:  Isadora Argou-Cardozo; Fares Zeidán-Chuliá
Journal:  Med Sci (Basel)       Date:  2018-04-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.